博晖创新：2025年第三季度主营收入2.25亿元 同比上升41.22%

Core Insights - The company reported a revenue of 629 million yuan for the first three quarters of 2025, representing a year-on-year decline of 2.68% [1] - The net profit attributable to the parent company was -33.6152 million yuan, a significant year-on-year decrease of 241.73% [1] - In the third quarter of 2025, the company achieved a single-quarter main business revenue of 225 million yuan, showing a year-on-year increase of 41.22% [1] Financial Performance - Total assets reached 4.326 billion yuan, reflecting a growth of 4.85% compared to the end of the previous year [1] - The company continues to focus on research and application in biotechnology, aiming to provide innovative biological solutions to customers [1] Business Strategy - The company is actively working on sales and marketing efforts to enhance its product market share [1]